Changing perceptions and efficacy of generic medicines: An intervention study.
- Published in:
- 2016
- By:
- Publication type:
- Journal Article
Works matching DE "GENERIC drugs"
Results: 3650
1
2
Impact of brand or generic labeling on medication effectiveness and side effects.
- Published in:
- 2016
- By:
- Publication type:
- Journal Article
3
Toward a generic conception of alcoholism.
- Published in:
- 1981
- By:
- Publication type:
- Journal Article
4
Renal patients' views on generic prescribing and substitution: example from the United Arab Emirates.
- Published in:
- Eastern Mediterranean Health Journal, 2013, v. 19, n. 4, p. 373, doi. 10.26719/2013.19.4.373
- By:
- Publication type:
- Article
5
Postmarketing pharmacokinetic and pharmacodynamic equivalence of generic and brand atenolol in Egypt.
- Published in:
- Eastern Mediterranean Health Journal, 2013, v. 19, p. S166, doi. 10.26719/2013.19.supp3.s166
- By:
- Publication type:
- Article
6
Controlling medicine prices in Sudan: the challenge of the recently established Medicines Regulatory Authority.
- Published in:
- Eastern Mediterranean Health Journal, 2012, v. 18, n. 8, p. 811, doi. 10.26719/2012.18.8.811
- By:
- Publication type:
- Article
7
Analysis of drug prescriptions in primary health care centres in Bahrain.
- Published in:
- Eastern Mediterranean Health Journal, 2010, v. 16, n. 5, p. 511, doi. 10.26719/2010.16.5.511
- By:
- Publication type:
- Article
8
Antimalarial prescribing and dispensing practices in health centres of Khartoum state, 2003-04.
- Published in:
- Eastern Mediterranean Health Journal, 2009, v. 15, n. 1, p. 122, doi. 10.26719/2009.15.1.122
- By:
- Publication type:
- Article
9
Ending the Shortage of Generic Oncology Drugs.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 17
- By:
- Publication type:
- Article
10
Degarelix for Advanced Prostate Cancer Gets Trade Name.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 810
- Publication type:
- Article
11
Antimicrobial drug-nutrition interactions: Consistency of information for generic drugs.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2020, v. 77, n. 10, p. 1073, doi. 10.2298/VSP181002191N
- By:
- Publication type:
- Article
12
Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs' reimbursements.
- Published in:
- European Journal of Health Economics, 2022, v. 23, n. 9, p. 1497, doi. 10.1007/s10198-022-01440-2
- By:
- Publication type:
- Article
13
Does NICE influence the adoption and uptake of generics in the UK?
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 2, p. 229, doi. 10.1007/s10198-020-01245-1
- By:
- Publication type:
- Article
14
The impact of physician-level drug budgets on prescribing behavior.
- Published in:
- 2018
- By:
- Publication type:
- journal article
15
The diffusion of generics after patent expiry in Germany.
- Published in:
- 2016
- By:
- Publication type:
- journal article
16
EQ-5D in skin conditions: an assessment of validity and responsiveness.
- Published in:
- 2015
- By:
- Publication type:
- journal article
17
Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?
- Published in:
- 2015
- By:
- Publication type:
- journal article
18
Western European markets for biosimilar and generic drugs: worth differentiating.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
19
Statistical and regulatory considerations in assessments of interchangeability of biological drug products.
- Published in:
- European Journal of Health Economics, 2014, v. 15, p. 5, doi. 10.1007/s10198-014-0589-1
- By:
- Publication type:
- Article
20
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
21
Competition in prescription drug markets: the roles of trademarks, advertising, and generic names.
- Published in:
- European Journal of Health Economics, 2013, v. 14, n. 4, p. 667, doi. 10.1007/s10198-012-0414-7
- By:
- Publication type:
- Article
22
Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data.
- Published in:
- European Journal of Health Economics, 2012, v. 13, n. 3, p. 301, doi. 10.1007/s10198-012-0377-8
- By:
- Publication type:
- Article
23
Generic substitution: micro evidence from register data in Norway.
- Published in:
- European Journal of Health Economics, 2011, v. 12, n. 1, p. 49, doi. 10.1007/s10198-010-0226-6
- By:
- Publication type:
- Article
24
Price regulation and generic competition in the pharmaceutical market.
- Published in:
- European Journal of Health Economics, 2006, v. 7, n. 3, p. 208, doi. 10.1007/s10198-006-0357-y
- By:
- Publication type:
- Article
25
Off-patent drugs in Italy.
- Published in:
- European Journal of Health Economics, 2006, v. 7, n. 1, p. 79, doi. 10.1007/s10198-005-0335-9
- By:
- Publication type:
- Article
26
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
- Published in:
- European Journal of Health Economics, 2005, v. 6, n. 3, p. 267, doi. 10.1007/s10198-005-0302-5
- By:
- Publication type:
- Article
27
Side effects of generic competition?
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 3, p. 203, doi. 10.1007/s10198-004-0234-5
- By:
- Publication type:
- Article
28
Dynamic competition in pharmaceuticals: Patent expiry, generic penetration, and industry structure.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 175, doi. 10.1007/s10198-003-0218-x
- By:
- Publication type:
- Article
29
Psikofarmakolojide Yeni Açılımlar; Tedavisel İlaç Kan Düzeyi Ölçümü.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S37
- By:
- Publication type:
- Article
30
Nematic Homopolymers: From Segmented to Wormlike Chains.
- Published in:
- Soft Materials, 2003, v. 1, n. 3, p. 313, doi. 10.1081/SMTS-120026964
- By:
- Publication type:
- Article
31
Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World.
- Published in:
- PLoS Medicine, 2010, v. 7, n. 8, p. 1, doi. 10.1371/journal.pmed.1000333
- By:
- Publication type:
- Article
32
Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia.
- Published in:
- PLoS Medicine, 2007, v. 4, n. 3, p. 0466, doi. 10.1371/journal.pmed.0040082
- By:
- Publication type:
- Article
33
The Other Collusion.
- Published in:
- Social Policy, 2019, v. 49, n. 2, p. 74
- By:
- Publication type:
- Article
34
The just price, exploitation, and prescription drugs: why free marketeers should object to profiteering by the pharmaceutical industry.
- Published in:
- Review of Social Economy, 2019, v. 77, n. 2, p. 108, doi. 10.1080/00346764.2018.1551561
- By:
- Publication type:
- Article
35
Simultaneous improvement in development time, cost and quality: a practical framework for generic pharmaceuticals industry.
- Published in:
- R&D Management, 2013, v. 43, n. 3, p. 227, doi. 10.1111/j.1467-9310.2012.00675.x
- By:
- Publication type:
- Article
36
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.
- Published in:
- Osteoporosis International, 2019, v. 30, n. 3, p. 649, doi. 10.1007/s00198-018-04821-7
- By:
- Publication type:
- Article
37
Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
- Published in:
- Osteoporosis International, 2017, v. 28, n. 1, p. 169, doi. 10.1007/s00198-016-3811-4
- By:
- Publication type:
- Article
38
Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists—a systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 5, p. 647, doi. 10.1007/s00228-025-03819-5
- By:
- Publication type:
- Article
39
A critical review on approaches to generate and validate virtual population for physiologically based pharmacokinetic models: Methodologies, case studies and way forward.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 12, p. 1903, doi. 10.1007/s00228-024-03763-w
- By:
- Publication type:
- Article
40
Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 355, doi. 10.1007/s00228-023-03603-3
- By:
- Publication type:
- Article
41
Untapped options to reduce waste from blister packaging for tablets and capsules.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 1, p. 151, doi. 10.1007/s00228-023-03594-1
- By:
- Publication type:
- Article
42
Within-subject pharmacokinetic variability has a strong influence on individual exposure ratios in bioequivalence studies, hence on drug formulation interchangeability.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 11, p. 1565, doi. 10.1007/s00228-023-03565-6
- By:
- Publication type:
- Article
43
Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 3, p. 419, doi. 10.1007/s00228-021-03209-7
- By:
- Publication type:
- Article
44
Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 11, p. 1575, doi. 10.1007/s00228-019-02738-6
- By:
- Publication type:
- Article
45
INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 275, doi. 10.1007/s00228-018-2580-8
- By:
- Publication type:
- Article
46
Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 4, p. 471, doi. 10.1007/s00228-016-2185-z
- By:
- Publication type:
- Article
47
Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 9, p. 1083, doi. 10.1007/s00228-015-1889-9
- By:
- Publication type:
- Article
48
Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 8, p. 979, doi. 10.1007/s00228-015-1878-z
- By:
- Publication type:
- Article
49
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 5, p. 549, doi. 10.1007/s00228-015-1832-0
- By:
- Publication type:
- Article
50
Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 7, p. 791, doi. 10.1007/s00228-014-1682-1
- By:
- Publication type:
- Article